»
Side Effects of Drugs Annual
 
 

Side Effects of Drugs Annual, 1st Edition

A worldwide yearly survey of new data in adverse drug reactions

 
Side Effects of Drugs Annual, 1st Edition,Jeffrey Aronson,ISBN9780444594990
 
 
Up to
25%
off
 

Side Effects of Drugs Annual

J Aronson   

Elsevier

9780444594990

9780444595034

904

240 X 165

Each new Annual continues to provide clinicians and medical investigators with a reliable and critical yearly survey of new data and trends in the area of adverse drug reactions and interactions

Print Book + eBook

USD 446.40
USD 744.00

Buy both together and save 40%

Print Book

Hardcover

In Stock

Estimated Delivery Time
USD 282.75
USD 377.00

eBook
eBook Overview

VST (VitalSource Bookshelf) format

DRM-free included formats : EPUB, Mobi (for Kindle), PDF

USD 275.25
USD 367.00
Add to Cart
 
 

Key Features

  • Provides a critical yearly survey of new data and trends
  • Special reviews in this Annual include, among other topics, epidemiology of the use of ecstasy, paracetamol and the risk of asthma, combination vaccines/multiple immunizations, interactions of herbal medicines with warfarin, and tyrosine kinase inhibitors

Description

The Side Effects of Drugs Annual was first published in 1977. It has been continually published since then as a yearly update to the voluminous encyclopedia, Meyler's Side Effects of Drugs. Each new Annual continues to provide clinicians and medical investigators with a reliable and critical yearly survey of new data and trends in the area of adverse drug reactions and interactions. An international team of specialists has contributed to the informative Annual by critically interpreting it and by pointing to whatever is misleading.

Readership

Pharmacologists, clinicians, pharmaceutical companies, clinical toxicologists, clinical pharmacologists and medical libraries

Jeffrey Aronson

Affiliations and Expertise

Reader in Clinical Pharmacology

View additional works by Jeffrey K Aronson

Side Effects of Drugs Annual, 1st Edition

Series Page

Contributors

Special reviews

Cumulative indexes of special reviews, Annuals 11–33

1. Index of drugs

2. Index of adverse reactions

Table of Essays, Annuals 1–33

Mechanistic and clinical descriptions of adverse drug reactions

1 EIDOS

2 DoTS

Definitive (between-the-eyes) adverse drug reactions

How to use this book

The scope of the Side Effects of Drugs Annuals

Period covered

Selection of material

Classification of drugs

Names of drugs and chemicals

System of tagging references

Indexes

Abbreviations

Side effects of drugs essay

An agenda for research into adverse drug reactions

Systematic reviews

Teleoanalysis

Conclusions

1. Central nervous system stimulants and drugs that suppress appetite

Amphetamines [SED-15, 180; SEDA-31, 1; SEDA-32, 1; SEDA-33, 1]

Methylxanthines

Drugs that suppress appetite [SEDA-30, 7; SEDA-31, 9; SEDA-32, 16; SEDA-33, 13]

Drugs used in Alzheimer’s disease [SEDA-31, 10; SEDA-32, 19; SEDA-33, 15]

References

2. Antidepressant drugs

General

Selective serotonin re-uptake inhibitors (SSRIs) [SED-15, 3109; SEDA-31, 18; SEDA-32, 33; SEDA-33, 26]

Serotonin and noradrenaline re-uptake inhibitors (SNRIs)

Tricyclic antidepressants

Other antidepressants

References

3. Lithium

References

4. Drugs of abuse

Cannabinoids [SED-15, 614; SEDA-31, 33; SEDA-32, 55; SEDA-33, 55]

Opioid analgesics

References

5. Hypnosedatives and anxiolytics

Azaspirones [SEDA-32, 75; SEDA-33, 71]

Benzodiazepines [SED-15, 429; SEDA-31, 57; SEDA-32, 75; SEDA-33, 71]

Benzodiazepine-like drugs

Benzodiazepine antagonists

Other hypnosedatives

References

6. Antipsychotic drugs

General [SED-15, 2438; SEDA-32, 83; SEDA-33, 89]

Individual drugs

References

7. Antiepileptic drugs

General

References

8. Opioid analgesics and narcotic antagonists

General

Opioid receptor agonists

Partial opioid receptor agonists

Opioid receptor antagonists

References

9. Anti-inflammatory and antipyretic analgesics and drugs used in gout

Amidopyrine and related compounds

Aniline derivatives [SED-15, 2679; SEDA-33, 244]

Anthranilic acid derivatives

Arylalkanoic acid derivatives [SED-15, 2555; SEDA-31, 186; SEDA-32, 229; SEDA-33, 245]

COX-2-selective inhibitors [SEDA-31, 190; SEDA-32, 232; SEDA-33, 246]

Indoleacetic acids [SEDA-33, 247]

Oxicams [SED-15, 2555; SEDA-32, 233; SEDA-33, 247]

Salicylates [SED-15, 15; SEDA-30, 128; SEDA-33, 248]

Miscellaneous drugs

Drugs used in the treatment of gout

References

10. General anesthetics and therapeutic gases

Anesthetic vapors [SEDA-31, 217; SEDA-32, 243; SEDA-33, 257]

Other vapors

Intravenous agents: Non-barbiturate anesthetics

Intravenous agents: Barbiturate anesthetics

References

11. Local anesthetics

General

Effects related to modes of use [SED-15, 2121; SEDA-31, 233; SEDA-32, 262; SEDA-33, 281]

Caudal, epidural, and spinal anesthesia

Tumescent anesthesia

Individual compounds

References

12. Neuromuscular blocking agents and skeletal muscle relaxants

Depolarizing neuromuscular blocking agents

Non-depolarizing neuromuscular blocking agents [SED-15, 2489; SEDA-31, 248; SEDA-32, 274; SEDA-33, 301]

Skeletal muscle relaxants

References

13. Drugs that affect autonomic functions or the extrapyramidal system

Drugs that stimulate both alpha- and beta-adrenoceptors [SEDA-31, 259; SEDA-32, 281; SEDA-33, 313]

Drugs that predominantly stimulate alpha1-adrenoceptors [SEDA-31, 264; SEDA-32, 283; SEDA-33, 318]

Drugs that stimulate beta1-adrenoceptors [SEDA-31, 265; SEDA-32, 284; SEDA-33, 265]

Drugs that stimulate beta2-adrenoceptors

Drugs that stimulate dopamine receptors [SEDA-31, 2039; SEDA-33, 266]

Other drugs that increase dopamine activity

Drugs that affect the cholinergic system [SEDA-31, 272; SEDA-32, 290; SEDA-33, 324]

References

14. Dermatological drugs, topical agents, and cosmetics

Cosmetics

Dermal fillers

Dyestuffs [SEDA-15, 1573; SEDA-31, 288; SEDA-32, 296]

Hair straighteners [SEDA-32, 296]

Fragrances

Glucocorticoids, topical

Phototherapy and photochemotherapy [SED-15, 2823; SEDA-32, 297]

Sunscreens

Vitamin A (retinoids) [SED-15, 3653; SEDA-32, 298; for vitamin A carotenoids seeChapter 34]

Vitamin D analogues, topical [SED-15, 594; SEDA-31, 293; SEDA-32, 301; for oral vitamin D analogues seeChapter 34]

References

15. Antihistamines (H1 receptor antagonists)

References

16. Drugs that act on the respiratory tract

Inhaled glucocorticoids [SEDA-31, 305; SEDA-32, 311; SEDA-33, 353]

Nasal glucocorticoids

Beta2-adrenoceptor agonists [SEDA-31, 308; SEDA-32, 314; SEDA-33, 357]

Anticholinergic drugs [SEDA-31, 311; SEDA-32, 318; SEDA-33, 363]

Leukotriene modifiers [SEDA-31, 312; SEDA-32, 319; SEDA-33, 366]

Phosphodiesterase type IV inhibitors [SEDA-31, 313; SEDA-32, 321; SEDA-33, 367]

References

17. Positive inotropic drugs and drugs used in dysrhythmias

Cardiac glycosides [SED-15, 648; SEDA-31, 321; SEDA-32, 333; SEDA-33, 377]

Herbal glycosides

Other positive inotropic drugs [SED-15, 2822; SEDA-31, 323; SEDA-32, 336; SEDA-33, 378]

Antidysrhythmic drugs

Adenosine receptor agonists [SEDA-31, 324; SEDA-32, 337; SEDA-33, 379]

References

18. Beta-adrenoceptor antagonists and antianginal drugs

Beta-adrenoceptor antagonists [SED-15, 452; SEDA-31, 339; SEDA-32, 363; SEDA-33, 397]

Potassium channel activators

Nitrates, organic [SED-15, 2529; SEDA-32, 366; SEDA-33, 400]

Calcium channel blockers [SED-15, 598; SEDA-31, 340; SEDA-32, 366; SEDA-33, 401]

References

19. Drugs acting on the cerebral and peripheral circulations

Drugs used in the treatment of arterial disorders of the brain and limbs

Drugs used in the treatment of venous disorders

Drugs used in the treatment of migraine

Other peripheral vasodilators

References

20. Antihypertensive drugs

General

Angiotensin-converting enzyme inhibitors [SED-15, 226; SEDA-31, 350; SEDA-32, 379; SEDA-33, 416]

Angiotensin II receptor antagonists [SED-15, 223; SEDA-31, 358; SEDA-32, 387; SEDA-33, 418]

Dual angiotensin II receptor antagonists/neprilysin antagonists

Direct renin inhibitors [SEDA-31, 360; SEDA-32, 388; SEDA-33, 420]

Endothelin receptor antagonists [SED-15, 1215; SEDA-31, 360; SEDA-32, 389; SEDA-33, 421]

Drugs that act on the sympathetic nervous system [SEDA-31, 362; SEDA-32, 391; SEDA-33, 424]

Postsynaptic α-adrenoceptor antagonists [SEDA-31, 363; SEDA-32, 391; SEDA-33, 425]

Direct vasodilators

References

21. Diuretics

Carbonic anhydrase inhibitors [SED-15, 643; SEDA-31, 371; SEDA-32, 403; SEDA-33, 437]

Thiazide and thiazide-like diuretics [SED-15, 3375; SEDA-31, 372; SEDA-32, 405; SEDA-33, 438]

Loop diuretics [SED-15, 567, 1454; SEDA-31, 375; SEDA-32, 408; SEDA-33, 440]

Aldosterone receptor antagonists

Spironolactone [SED-15, 3176; SEDA-31, 375; SEDA-32, 409; SEDA-33, 440]

Osmotic diuretics

References

22. Metals

References

23. Metal antagonists

Iron chelators

Penicillamine and related drugs [SED-15, 2729; SEDA-31, 403; SEDA-32, 430; SEDA-33, 472]

Other chelators

Polystyrene sulfonates [SED-15, 2894; SEDA-32, 433; SEDA-33, 474]

References

24. Antiseptic drugs and disinfectants

Aldehydes [SED-15, 1439, 1513; SEDA-31, 409; SEDA-32, 437; SEDA-33, 479]

Bisbiguanides

Cationic surfactants

Halogens

Iodophors [SED-15, 1896; SEDA-31, 411; SEDA-32, 440; SEDA-33, 485]

Phenolic compounds [SED-15, 2800; SEDA-32, 441; SEDA-33, 485]

References

25. Penicillins, cephalosporins, other beta-lactam antibiotics, and tetracyclines

Beta-lactam antibiotics [SED-15, 478; SEDA-31, 420; SEDA-32, 447; SEDA-33, 491]

Carbapenems [SED-15, 638; SEDA-31, 420; SEDA-32, 448; SEDA-33, 491]

Cephalosporins [SED-15, 688; SEDA-31, 422; SEDA-32, 448; SEDA-33, 493]

Monobactams and monocarbams [SED-15, 2378; SEDA-31, 423; SEDA-32, 450; SEDA-33, 494]

Penicillins [SED-15, 2756; SEDA-31, 424; SEDA-32, 450; SEDA-33, 495]

Tetracyclines and glycylcyclines [SED-15, 3330; SEDA-31, 419; SEDA-32, 451; SEDA-33, 497]

References

26. Miscellaneous antibacterial drugs

Aminoglycosides [SED-15, 118; SEDA-31, 427; SEDA-32, 461; SEDA-33, 509]

Fluoroquinolones [SED-15, 1396; SEDA-31, 429; SEDA-32, 464; SEDA-33, 514]

Glycopeptides [SEDA-31, 435; SEDA-32, 469; SEDA-33, 519]

Ketolides [SED-15, 1976; SEDA-31, 436; SEDA-32, 471; SEDA-33, 521]

Lincosamides [SED-15, 2063; SEDA-31, 437; SEDA-32, 472; SEDA-33, 522]

Macrolides [SED-15, 2183; SEDA-31, 437; SEDA-32, 472; SEDA-33, 522]

Nitrofurantoin [SED-15, 2542; SEDA-31, 439; SEDA-32, 476; SEDA-33, 525]

Oxazolidinones [SED-15, 2645; SEDA-31, 439; SEDA-32, 474; SEDA-33, 525]

Polymyxins [SED-15, 2891; SEDA-31, 441; SEDA-32, 476; SEDA-33, 527]

Streptogramins [SED-15, 3182; SEDA-31, 442; SEDA-32, 528]

Sulfonamides, trimethoprim, and co-trimoxazole [SED-15, 3216, 3510; SEDA-31, 442; SEDA-32, 477; SEDA-33, 528]

Other antimicrobial drugs

References

27. Antifungal drugs

Allylamines [SEDA-31, 457; SEDA-32, 491; SEDA-33, 541]

Amphotericin [SED-15, 192; SEDA-31, 458; SEDA-32, 493; SEDA-33, 542]

Antifungal azoles [SED-15, 301; SEDA-31, 459; SEDA-32, 497; SEDA-33, 545]

Echinocandins [SED-15, 1197; SEDA-31, 464; SEDA-32, 507; SEDA-33, 556]

Flucytosine [SED-15, 1388; SEDA-32, 497; SEDA-33, 000]

References

28. Antiprotozoal drugs

Antimalarial drugs

4-Aminoquinolines (chloroquine and congeners) [SEDA-31, 469; SEDA-32, 521; SEDA-33, 567]

Primaquine and congeners [SED-15, 2919; SEDA-33, 569]

Endoperoxides [SED-15, 342; SEDA-31, 473; SEDA-32, 525; SEDA-33, 571]

Drugs used in the treatment of other protozoal infections

Miscellaneous drugs

References

29. Antiviral drugs

Drugs active against cytomegalovirus

Drugs active against herpesviruses [SEDA-31, 478; SEDA-32, 530; SEDA-33, 577]

Drugs active against hepatitis viruses

Drugs active against human immunodeficiency virus: Combinations

Drugs active against human immunodeficiency virus: Nucleoside analogue reverse transcriptase inhibitors (NRTI) [SED-15, 2586; SEDA-31, 482; SEDA-32, 534; SEDA-33, 585]

Drugs active against human immunodeficiency virus: Nucleotide analogue reverse transcriptase inhibitors

Drugs active against human immunodeficiency virus: Non-nucleoside reverse transcriptase inhibitors (NNRTI) [SED-15, 2553; SEDA-31, 486; SEDA-32, 537; SEDA-33, 590]

Drugs active against human immunodeficiency virus: Protease inhibitors [SED-15, 2586; SEDA-31, 487; SEDA-32, 541; SEDA-33, 593]

Drugs active against human immunodeficiency virus: Inhibitors of HIV fusion [SEDA-28, 337; SEDA-33; 598; SEDA-33, 598]

Drugs active against human immunodeficiency virus: Integrase inhibitors [SEDA-33, 599]

Drugs active against human immunodeficiency virus: Chemokine receptor CCR5 antagonists [SEDA-33, 600]

Drugs active against influenza viruses: Neuraminidase inhibitors [SED-15, 2436; SEDA-31, 489; SEDA-32, 544; SEDA-33, 601]

Drugs active against influenza viruses: Ion channel inhibitors [SED-15, 105, 3051; SEDA-31, 489; SEDA-32, 544; SEDA-33, 269, 602]

References

30. Drugs used in tuberculosis and leprosy

Rifamycins [SED-15, 3040; SEDA-31, 498; SEDA-32, 563; SEDA-33, 637]

References

31. Antihelminthic drugs

Benzimidazoles [SED-15, 424; SEDA-31, 508; SEDA-32, 572; SEDA-33, 647]

References

32. Vaccines

General

Bacterial vaccines

Viral vaccines

Other components of vaccines

References

33. Blood, blood components, plasma, and plasma products

Albumin and derivatives [SED-15, 54; SEDA-31, 527; SEDA-32, 591; SEDA-33, 670]

Blood transfusion [SED-15, 529; SEDA-31, 528; SEDA-32, 593; SEDA-33, 671]

Blood substitutes [SEDA-31, 531; SEDA-32, 593; SEDA-33, 672]

Plasma and plasma products [SED-15, 2847; SEDA-31, 532; SEDA-32, 594; SEDA-33, 674]

Plasma substitutes [SEDA-31, 533; SEDA-32, 594; SEDA-33, 675]

Globulins

Coagulation proteins [SED-15, 845; SEDA-31, 537; SEDA-32, 596; SEDA-33, 679]

Erythropoietin and derivatives [SED-15, 1243; SEDA-31, 538; SEDA-32, 597; SEDA-33, 681]

Stem cells [SEDA-31, 539; SEDA-32, 599; SEDA-33, 682]

References

34. Vitamins, intravenous solutions, and drugs and formulations used in nutrition

Vitamin A (carotenoids) [SED-15, 3642; SEDA-31, 548; SEDA-32, 607; SEDA-33, 691]

Vitamins of the B group [SED-15, 2700; SEDA-31, 548; SEDA-32, 608; SEDA-33, 693]

Vitamin C (ascorbic acid) [SED-15, 351; SEDA-31, 548; SEDA-32, 611; SEDA-33, 694]

Vitamin D analogues [SED-15, 3669; SEDA-31, 549; SEDA-32, 612; SEDA-33, 695]

Vitamin E (tocopherol) [SED-15, 3677; SEDA-31, 549; SEDA-32, 612; SEDA-33, 696]

Vitamin K analogues [SED-15, 3681; SEDA-29, 355]

Parenteral nutrition [SED-15, 2700; SEDA-31, 549; SEDA-32, 613; SEDA-33, 697]

Enteral nutrition [SED-15, 1221; SEDA-30, 396; SEDA-33, 700]

References

35. Drugs that affect blood coagulation, fibrinolysis, and hemostasis

Coumarin anticoagulants [SED-15, 983; SEDA-31, 553; SEDA-32, 617; SEDA-33, 707]

Heparins [SED-15, 1590; SEDA-31, 556; SEDA-32, 626; SEDA-33, 713]

Direct thrombin inhibitors [SED-15, 1142; SEDA-30, 409; SEDA-31, 559; SEDA-32, 632; SEDA-33, 717]

Direct factor Xa inhibitors [SEDA-31, 561; SEDA-32, 635]

Indirect factor Xa Inhibitors [SEDA-31, 563; SEDA-32, 636; SEDA-33, 636]

Thrombolytic drugs

Drugs that alter platelet function [SEDA-30, 413; SEDA-31, 564; SEDA-32, 637; SEDA-33, 637]

Glycoprotein IIb–IIIa inhibitors [SED-15, 4; SEDA-31, 565; SEDA-32, 638; SEDA-33, 720]

Thienopyridines [SED-15, 821; SEDA-31, 566; SEDA-32, 639; SEDA-33, 720]

Hemostatic agents

References

36. Gastrointestinal drugs

Antacids [SED-15, 243; SEDA-31, 573; SEDA-32, 665; SEDA-33, 741]

Antiemetics and drugs that affect gastrointestinal motility [SEDA-31, 573; SEDA-32, 665; SEDA-33, 741]

5HT3 receptor antagonists [SED-15, 1365; SEDA-31, 575; SEDA-32, 666; SEDA-33, 744]

Neurokinin NK1 receptor antagonists [SEDA-32, 667; SEDA-33, 748]

Histamine H2 receptor antagonists [SED-15, 1629; SEDA-31, 576; SEDA-32, 667; SEDA-33, 748]

Proton pump inhibitors [SED-15, 2973; SEDA-31, 577; SEDA-32, 667; SEDA-33, 749]

Other ulcer-healing agents

Laxatives and oral bowel preparations [SED-15, 2008; SEDA-31, 581; SEDA-32, 668; SEDA-33, 753]

Aminosalicylates [SED-15, 138; SEDA-31, 583; SEDA-32, 669; SEDA-33, 756]

Antidiarrheal agents

Other gastrointestinal agents

References

37. Drugs that act on the immune system: cytokines and monoclonal antibodies

Colony-stimulating factors [SEDA-31, 589; SEDA-32, 675; SEDA-33, 769]

Interferons [SED-15, 1841; SEDA-31, 591; SEDA-32, 676; SEDA-33, 773]

Interleukins [SED-15, 1831; SEDA-31, 592; SEDA-32, 676; SEDA-33, 777]

Tumor necrosis factor alfa (TNF-α) and its antagonists [SEDA-31, 592; SEDA-32, 677; SEDA-33, 779]

Monoclonal antibodies [SED-15, 2380; SEDA-31, 602; SEDA-32, 686; SEDA-33, 783]

References

38. Drugs that act on the immune system

Thiopurines [SED-15, 377; SEDA-31, 635; SEDA-32, 717; SEDA-33, 824]

Immunoenhancing drugs

References

39. Corticotrophins, corticosteroids, and prostaglandins

Systemic glucocorticoids [SED-15, 906; SEDA-31, 651; SEDA-32, 723; SEDA-33, 841]

Prostaglandins and analogues [SED-15, 2955; SEDA-31, 651; SEDA-32, 729; SEDA-33, 846]

References

40. Sex hormones and related compounds, including hormonal contraceptives

Estrogens [SED-15, 1253; SEDA-31, 657; SEDA-32, 736; SEDA-33, 852]

Hormonal contraceptives [SED-15, 1642; SEDA-31, 663; SEDA-32, 741; SEDA-33, 858]

Antiestrogens and selective estrogen receptor modulators (SERMs) [SEDA-31, 664; SEDA-32, 743; SEDA-33, 859]

Progestogens [SED-15, 2930; SEDA-31, 669; SEDA-32, 747; SEDA-33, 865]

Prostaglandins (See alsoChapters 39 and 47)

Progesterone antagonists [SEDA-31, 671; SEDA-32, 749; SEDA-33, 866]

Sex hormone antagonists

Anabolic steroids, androgens, and related compounds [SED-15, 216; SEDA-31, 672; SEDA-32, 751; SEDA-33, 868]

Antiandrogens [SEDA-31, 673; SEDA-32, 755; SEDA-33, 872]

References

41. Thyroid hormones, iodine, and antithyroid drugs

Thyroid hormones [SED-15, 3409; SEDA-31, 687; SEDA-32, 763; SEDA-33, 881]

Iodine and iodides [SED-15, 1896; SEDA-31, 688; SEDA-32, 764; SEDA-33, 883]

Antithyroid drugs [SED-15, 3387; SEDA-31, 689; SEDA-32, 765; SEDA-33, 884]

References

42. Insulin, other hypoglycemic drugs, and glucagon

Insulin [SED-15, 1761; SEDA-31, 689; SEDA-32, 769; SEDA-33, 889]

Amylin analogues [SEDA-31, 692; SEDA-32, 773; SEDA-33, 893]

Biguanides [SED-15, 506; SEDA-31, 692; SEDA-32, 773; SEDA-33, 893]

Dipeptidyl peptidase 4 (DDP-4) inhibitors [SEDA-31, 693; SEDA-32, 774; SEDA-33, 894]

Incretin mimetics [SEDA-31, 695; SEDA-32, 775; SEDA-33, 896]

Meglitinides [SED-15, 2238; SEDA-31, 695; SEDA-32, 776; SEDA-33, 897]

Sodium–glucose transporter type 2 (SGLT2) inhibitors [SEDA-33, 898]

Sulfonylureas [SED-15, 3230; SEDA-31, 695; SEDA-32, 777; SEDA-33, 898]

Thiazolidinediones (Glitazones) [SED-15, 3380; SEDA-31, 697; SEDA-32, 779; SEDA-33, 899]

Peroxisome proliferator-activated dual receptor agonists [SEDA-32, 782; SEDA-33, 902]

References

43. Miscellaneous hormones

Vasopressin receptor antagonists

Vasopressin and analogues [SED-15, 3609; SEDA-31, 710; SEDA-32, 798; SEDA-33, 915]

References

44. Drugs that affect lipid metabolism

Cholesteryl ester transfer proteins [SEDA-32, 817; SEDA-33, 929]

Fibrates [SED-15, 1358; SEDA-32, 804; SEDA-33, 922]

HMG-CoA REDUCTASE INHIBITORS [SED-15, 1632; SEDA-31, 715; SEDA-32, 807; SEDA-33, 924]

Nicotinic acid derivatives [SED-15, 2512; SEDA-32, 815; SEDA-33, 928]

References

45. Cytostatic and cytotoxic drugs

Pyrimidine analogues and fluoropyrimidines

Pyrimidine analogues

Fluoropyrimidines

References

46. Radiological contrast agents and radiopharmaceuticals

MRI contrast media

Ultrasound contrast agents [SED-15, 3543; SEDA-32, 855; SEDA-33, 971]

Radiopharmaceuticals [SED-15, 3017; SEDA-33, 973]

References

47. Drugs used in ocular treatment

Drugs used in the management of macular degeneration [SEDA-31, 739; SEDA-32, 865; SEDA-33, 977]

Adrenoceptor agonists [SEDA-31, 740; SEDA-32, 869; SEDA-33, 982]

Alpha-adrenoceptor agonists

Antibacterial drugs

Anticholinergic drugs

Carbonic anhydrase inhibitors

Glucocorticosteroids [SED-15, 906; SEDA-31, 741; SEDA-32, 871; SEDA-33, 983]

Non-steroidal anti-inflammatory drugs

Prostaglandin analogues (See also Chapter 39)[SEDA-32, 871; SEDA-33, 984]

Procedures

References

48. Treatments used in complementary and alternative medicine

Asian herbal medicines [SED-15, 1609; SEDA-32, 879]

Oral formulations of traditional Chinese medicines

Topical formulations of traditional Chinese medicines

Injectable formulations of Chinese medicines

Nutritional supplements

Specific plants

Acupuncture

Infrared heat and massage therapy

References

49. Miscellaneous drugs, materials, medical devices, and techniques

DyestuffS

Sclerosants [SED-15, 3107; SEDA-33, 1021]

References

Index of drugs

Index of drug-drug interactions

Index of adverse effects and adverse reactions

 
 
Free Shipping
Shop with Confidence

Free Shipping around the world
▪ Broad range of products
▪ 30 days return policy
FAQ

Contact Us